Treatment Advances in Digestive Diseases

Helicobacter pylori (H. pylori) infection is a typical infection which is the major cause of peptic ulcer disease and gastric cancer. Most people with H. pylori infection will never have any signs or symptoms. Diagnosis of this disease can be done using blood test, breath test, stool test, scope test. Treatment can be done using Proton pump inhibitors, Histamine (H-2) blockers, Bismuth subsalicylate.

Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used drugs and their widespread use is associated with increased gastro-intestinal toxic effects such as ulceration, haemorrhage, perforation and death.

Using of Lansoprazole in the prophylaxis of acid aspiration during elective surgery is one the advance treatment in Digestive diseases.

  • Helicobacter Pylori Treatment
  • Nonsteroidal anti-inflammatory drugs
  • Proton-pump inhibitors
  • Prophylaxis with Lansoprazole

Related Conference of Treatment Advances in Digestive Diseases

March 18-19, 2020

International Conference on Gastroenterology and Liver

Amsterdam, Netherlands
March 18-19, 2020

11th International conference on Liver and Hepatitis

Amsterdam, Netherlands
March 30-31, 2020

7th International Conference on Hepatology

Osaka, Japan
June 24-25, 2020

15th Euro-Global Gastroenterology Conference

Rome, Italy
July 20-21, 2020

20th World Gastroenterologists Summit

Osaka, Japan
September 28-29. 2020

3rd World Liver Congress

Abu Dhabi, UAE
November 16-17, 2020

30th World Congress on Nursing

Brisbane, Australia
December 07-08 , 2020

International Congress on Gastroenterology and Liver Transplant

Auckland, Newzeland

Treatment Advances in Digestive Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in